Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 4
1992 6
1993 50
1994 67
1995 81
1996 104
1997 129
1998 116
1999 116
2000 100
2001 87
2002 99
2003 125
2004 83
2005 112
2006 111
2007 98
2008 94
2009 120
2010 115
2011 114
2012 113
2013 125
2014 123
2015 152
2016 137
2017 147
2018 155
2019 161
2020 147
2021 144
2022 110
2023 96
2024 99
2025 101
2026 41

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,407 results

Results by year

Filters applied: . Clear all
Page 1
Zarxio--a filgrastim biosimilar.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2016 Mar 14;58(1490):34-5. Med Lett Drugs Ther. 2016. PMID: 26963154 Review. No abstract available.
Filgrastim induced thrombocytopenia.
Kango G, Haroun F. Kango G, et al. BMJ Case Rep. 2020 Jun 30;13(6):e234584. doi: 10.1136/bcr-2020-234584. BMJ Case Rep. 2020. PMID: 32606115 Free PMC article.
The diagnosis is ascertained when there is reproducibility of thrombocytopenia with repeated exposure. Filgrastim is used during peripheral blood progenitor cell harvest during autologous stem cell transplantation in the setting of multiple myeloma to prolong event-free su …
The diagnosis is ascertained when there is reproducibility of thrombocytopenia with repeated exposure. Filgrastim is used during peri …
Bring on the Biosimilars!
Avalos BR. Avalos BR. Biol Blood Marrow Transplant. 2015 Nov;21(11):1859-60. doi: 10.1016/j.bbmt.2015.09.010. Epub 2015 Sep 18. Biol Blood Marrow Transplant. 2015. PMID: 26386317 Free article. No abstract available.
A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer.
Zhang Q, Wang Z, Yao W, Wang S, Zhang G, Chen J, Hou Q, Li S, Li H, Ye C, Sun T, Yang H, Chen Z, Wang Z, Liu X, Geng C, Li X, Zhang J, Zheng H, Shao Z. Zhang Q, et al. BMC Cancer. 2024 Sep 13;24(1):1143. doi: 10.1186/s12885-024-12892-5. BMC Cancer. 2024. PMID: 39272058 Free PMC article. Clinical Trial.
Results for all efficacy endpoints in cycles 2 - 4 were consistent with the results in cycle 1, however a trend towards a lower incidence and a shorter duration of grade 3 or 4 neutropenia and grade 4 neutropenia was observed in the F-627 group compared with the filgrastim …
Results for all efficacy endpoints in cycles 2 - 4 were consistent with the results in cycle 1, however a trend towards a lower incidence an …
Filgrastim, fibrinolysis, and neovascularization.
Eton D, Zhou G, He TC, Bartholomew A, Patil R. Eton D, et al. J Tissue Eng Regen Med. 2022 May;16(5):496-510. doi: 10.1002/term.3284. Epub 2022 Feb 17. J Tissue Eng Regen Med. 2022. PMID: 35175691 Free PMC article.
In the PCP-alone group, blood was sampled on Day 1 (baseline) and after 30 days of daily PCP. In the Filgrastim and PCP group, blood was drawn on Day 1, and 1 day after the 5th and the 10th Filgrastim doses. ...Filgrastim at this novel dosimetry induced fibri …
In the PCP-alone group, blood was sampled on Day 1 (baseline) and after 30 days of daily PCP. In the Filgrastim and PCP group, blood …
[Biosimilar drugs in oncology].
Levêque D. Levêque D. Bull Cancer. 2016 Mar;103(3):294-8. doi: 10.1016/j.bulcan.2015.12.004. Epub 2016 Jan 29. Bull Cancer. 2016. PMID: 26832422 Review. French.
Current available biosimilars in oncology are filgrastim and epoietin alpha. In the next future, will be launched rituximab and trastuzumab. ...
Current available biosimilars in oncology are filgrastim and epoietin alpha. In the next future, will be launched rituximab and trast …
Totality of the evidence at work: The first U.S. biosimilar.
Holzmann J, Balser S, Windisch J. Holzmann J, et al. Expert Opin Biol Ther. 2016;16(2):137-42. doi: 10.1517/14712598.2016.1128410. Epub 2015 Dec 23. Expert Opin Biol Ther. 2016. PMID: 26634611
On March 6(th) 2015, the Food and Drug Administration (FDA) approved filgrastim-sndz (Zarxio) as the first biosimilar in the United States (US) for all indications of the reference product. Filgrastim-sndz is a biosimilar of Amgen's Neupogen and is mainly used to tr …
On March 6(th) 2015, the Food and Drug Administration (FDA) approved filgrastim-sndz (Zarxio) as the first biosimilar in the United S …
Neulasta Onpro: a coup de grâce?
Jensen CJ, Scheckel CJ, Go RS, Desai A, Soefje SA. Jensen CJ, et al. Am J Manag Care. 2023 Mar 1;29(3):e69-e70. doi: 10.37765/ajmc.2023.89331. Am J Manag Care. 2023. PMID: 36947018 Free article.
3,407 results